MedChem Express

MedChem Express logo

MedChemExpress has an experienced team of custom synthesis chemists, led by an impressive group of Ph.D.'s. With this team, we have the capability of supporting all kinds of chemistry projects of multiple step syntheses of complex labeled molecules, including metabolites and steroids. Following scientific and technological innovation, challenging traditional thinking, MedChemExpress has always been committed to develop quality products that exceed international standards on cost and reliability, to create the most advanced synthetic route. With high experiences in preparing a large numbers of different biologically active molecules, we provide rapid synthesis of new products. That is why we can consistently deliver your custom synthesis compounds faster than any other company.

Company Website

Product Listing

(+)-Cloprostenol 1mg  | ≥98%

MedChem Express

(+)-Cloprostenol is a prostaglandin F2α (PGF2α) analogue, and shows selective agonistic activity at the prostaglandin receptor. In Vitro: D-Cloprostenol and PGF2 alpha are equipotent, about 150 times more potent than dl-cloprostenol (P < 0.05) and approximately 280 times more potent than PGE1 in inhibiting [3H]PGF2 alpha binding to corpus luteum cell membranes. However, d-cloprostenol and […]

More Information Supplier Page

(+)-Cloprostenol 5mg  | ≥98%

MedChem Express

(+)-Cloprostenol is a prostaglandin F2α (PGF2α) analogue, and shows selective agonistic activity at the prostaglandin receptor. In Vitro: D-Cloprostenol and PGF2 alpha are equipotent, about 150 times more potent than dl-cloprostenol (P < 0.05) and approximately 280 times more potent than PGE1 in inhibiting [3H]PGF2 alpha binding to corpus luteum cell membranes. However, d-cloprostenol and […]

More Information Supplier Page

(+)-Cloprostenol 10mg  | ≥98%

MedChem Express

(+)-Cloprostenol is a prostaglandin F2α (PGF2α) analogue, and shows selective agonistic activity at the prostaglandin receptor. In Vitro: D-Cloprostenol and PGF2 alpha are equipotent, about 150 times more potent than dl-cloprostenol (P < 0.05) and approximately 280 times more potent than PGE1 in inhibiting [3H]PGF2 alpha binding to corpus luteum cell membranes. However, d-cloprostenol and […]

More Information Supplier Page

(+)-Cloprostenol 25mg  | ≥98%

MedChem Express

(+)-Cloprostenol is a prostaglandin F2α (PGF2α) analogue, and shows selective agonistic activity at the prostaglandin receptor. In Vitro: D-Cloprostenol and PGF2 alpha are equipotent, about 150 times more potent than dl-cloprostenol (P < 0.05) and approximately 280 times more potent than PGE1 in inhibiting [3H]PGF2 alpha binding to corpus luteum cell membranes. However, d-cloprostenol and […]

More Information Supplier Page

(+)-Cloprostenol 10mM/1mL  | ≥98%

MedChem Express

(+)-Cloprostenol is a prostaglandin F2α (PGF2α) analogue, and shows selective agonistic activity at the prostaglandin receptor. In Vitro: D-Cloprostenol and PGF2 alpha are equipotent, about 150 times more potent than dl-cloprostenol (P < 0.05) and approximately 280 times more potent than PGE1 in inhibiting [3H]PGF2 alpha binding to corpus luteum cell membranes. However, d-cloprostenol and […]

More Information Supplier Page

(+)-DHMEQ 10mM/1mL  | ≥98%

MedChem Express

(+)-DHMEQ is an activator of antioxidant transcription factor Nrf2. (+)-DHMEQ is the enantiomer of (-)-DHMEQ. (-)-DHMEQ inhibits NF-kB than its enantiomer (+)-DHMEQ. IC50 & Target: Nrf2[1] In Vitro: (+)-DHMEQ ((2R,3R,4R)-DHMEQ) activates Nrf2, which is a transcription factor that induces the expression of multiple antioxidant enzymes. (+)-DHMEQ activates Nrf2 in a promoter reporter assay. (+)-DHMEQ also […]

More Information Supplier Page

(+)-DHMEQ 2mg  | ≥98%

MedChem Express

(+)-DHMEQ is an activator of antioxidant transcription factor Nrf2. (+)-DHMEQ is the enantiomer of (-)-DHMEQ. (-)-DHMEQ inhibits NF-kB than its enantiomer (+)-DHMEQ. IC50 & Target: Nrf2[1] In Vitro: (+)-DHMEQ ((2R,3R,4R)-DHMEQ) activates Nrf2, which is a transcription factor that induces the expression of multiple antioxidant enzymes. (+)-DHMEQ activates Nrf2 in a promoter reporter assay. (+)-DHMEQ also […]

More Information Supplier Page

(+)-DHMEQ 5mg  | ≥98%

MedChem Express

(+)-DHMEQ is an activator of antioxidant transcription factor Nrf2. (+)-DHMEQ is the enantiomer of (-)-DHMEQ. (-)-DHMEQ inhibits NF-kB than its enantiomer (+)-DHMEQ. IC50 & Target: Nrf2[1] In Vitro: (+)-DHMEQ ((2R,3R,4R)-DHMEQ) activates Nrf2, which is a transcription factor that induces the expression of multiple antioxidant enzymes. (+)-DHMEQ activates Nrf2 in a promoter reporter assay. (+)-DHMEQ also […]

More Information Supplier Page

(+)-DHMEQ 10mg  | ≥98%

MedChem Express

(+)-DHMEQ is an activator of antioxidant transcription factor Nrf2. (+)-DHMEQ is the enantiomer of (-)-DHMEQ. (-)-DHMEQ inhibits NF-kB than its enantiomer (+)-DHMEQ. IC50 & Target: Nrf2[1] In Vitro: (+)-DHMEQ ((2R,3R,4R)-DHMEQ) activates Nrf2, which is a transcription factor that induces the expression of multiple antioxidant enzymes. (+)-DHMEQ activates Nrf2 in a promoter reporter assay. (+)-DHMEQ also […]

More Information Supplier Page

(+)-DHMEQ 25mg  | ≥98%

MedChem Express

(+)-DHMEQ is an activator of antioxidant transcription factor Nrf2. (+)-DHMEQ is the enantiomer of (-)-DHMEQ. (-)-DHMEQ inhibits NF-kB than its enantiomer (+)-DHMEQ. IC50 & Target: Nrf2[1] In Vitro: (+)-DHMEQ ((2R,3R,4R)-DHMEQ) activates Nrf2, which is a transcription factor that induces the expression of multiple antioxidant enzymes. (+)-DHMEQ activates Nrf2 in a promoter reporter assay. (+)-DHMEQ also […]

More Information Supplier Page

(+)-JQ-1 5mg  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 10mg  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 50mg  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 100mg  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 1g  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 200mg  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 500mg  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 10mM/1mL  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ-1 5g  | ≥98%

MedChem Express

(+)-JQ-1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)). IC50 & Target: IC50: 77/33 nM (BRD4(1/2))[1] In Vitro: (+)-JQ1 represents a potent, highly specific and Kac competitive inhibitor for the BET family of bromodomains. (+)-JQ1 (100 nM, 48 h) prompts squamous differentiation exhibited by cell […]

More Information Supplier Page

(+)-JQ1 PA 10mM/1mL  | ≥98%

MedChem Express

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 100mg  | ≥98%

MedChem Express

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 50mg  | ≥98%

MedChem Express

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 25mg  | ≥98%

MedChem Express

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 5mg  | ≥98%

MedChem Express

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 10mg  | ≥98%

MedChem Express

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-Ketoconazole 10mM/1mL  | ≥98%

MedChem Express

(+)-Ketoconazole is an imidazole anti-fungal agent, a CYP3A4 inhibitor. Target: CYP3A4 (+)-Ketoconazole, an imidazole anti-fungal agent, has often produced features of androgen deficiency including decreased libido, gynecomastia, impotence, oligospermia, and decreased testosterone levels, in men being treated for chronic mycotic infections [1]. (+)-Ketoconazole also is a cytochrome P450 inhibitor [2]. (+)-Ketoconazole (KTZ), on the antischistosomal […]

More Information Supplier Page

(+)-Ketoconazole 50mg  | ≥98%

MedChem Express

(+)-Ketoconazole is an imidazole anti-fungal agent, a CYP3A4 inhibitor. Target: CYP3A4 (+)-Ketoconazole, an imidazole anti-fungal agent, has often produced features of androgen deficiency including decreased libido, gynecomastia, impotence, oligospermia, and decreased testosterone levels, in men being treated for chronic mycotic infections [1]. (+)-Ketoconazole also is a cytochrome P450 inhibitor [2]. (+)-Ketoconazole (KTZ), on the antischistosomal […]

More Information Supplier Page

(+)-Ketoconazole 10mg  | ≥98%

MedChem Express

(+)-Ketoconazole is an imidazole anti-fungal agent, a CYP3A4 inhibitor. Target: CYP3A4 (+)-Ketoconazole, an imidazole anti-fungal agent, has often produced features of androgen deficiency including decreased libido, gynecomastia, impotence, oligospermia, and decreased testosterone levels, in men being treated for chronic mycotic infections [1]. (+)-Ketoconazole also is a cytochrome P450 inhibitor [2]. (+)-Ketoconazole (KTZ), on the antischistosomal […]

More Information Supplier Page

(+)-MK 801 (Maleate) 10mM/1mL  | ≥98%

MedChem Express

(+)-MK 801 (Maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes. IC50 & Target: Ki: 37.2 nM (NMDA receptor, in rat brain membrane)[1] In Vitro: [3H]MK-801 binds with NMDA receptor with a Kd of 37.2 ±2.7 nM in rat cerebral cortical membranes[1]. MK-801 shows an inhibitory activity against N-methyl-D-aspartate-induced […]

More Information Supplier Page

(+)-MK 801 (Maleate) 50mg  | ≥98%

MedChem Express

(+)-MK 801 (Maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes. IC50 & Target: Ki: 37.2 nM (NMDA receptor, in rat brain membrane)[1] In Vitro: [3H]MK-801 binds with NMDA receptor with a Kd of 37.2 ±2.7 nM in rat cerebral cortical membranes[1]. MK-801 shows an inhibitory activity against N-methyl-D-aspartate-induced […]

More Information Supplier Page

(+)-MK 801 (Maleate) 10mg  | ≥98%

MedChem Express

(+)-MK 801 (Maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes. IC50 & Target: Ki: 37.2 nM (NMDA receptor, in rat brain membrane)[1] In Vitro: [3H]MK-801 binds with NMDA receptor with a Kd of 37.2 ±2.7 nM in rat cerebral cortical membranes[1]. MK-801 shows an inhibitory activity against N-methyl-D-aspartate-induced […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 5mg  | ≥98%

MedChem Express

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 10mg  | ≥98%

MedChem Express

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 25mg  | ≥98%

MedChem Express

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 50mg  | ≥98%

MedChem Express

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 10mM/1mL  | ≥98%

MedChem Express

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-SJ733 10mM/1mL  | ≥98%

MedChem Express

(+)-SJ733 is a clinical candidate for malaria which can also inhibit Na+-ATPase PfATP4. IC50 & Target: Parasite, Na+-ATPase PfATP4[1] In Vitro: (+)-SJ733 binds to a single receptor site in P. falciparum-infected erythrocytes with equivalent affinity to its growth-inhibitory potency (kd=50 nM). (+)-SJ733 has not exhibited either significant safety liabilities at any dose in extensive profiling […]

More Information Supplier Page

(+)-SJ733 1mg  | ≥98%

MedChem Express

(+)-SJ733 is a clinical candidate for malaria which can also inhibit Na+-ATPase PfATP4. IC50 & Target: Parasite, Na+-ATPase PfATP4[1] In Vitro: (+)-SJ733 binds to a single receptor site in P. falciparum-infected erythrocytes with equivalent affinity to its growth-inhibitory potency (kd=50 nM). (+)-SJ733 has not exhibited either significant safety liabilities at any dose in extensive profiling […]

More Information Supplier Page

(+)-SJ733 5mg  | ≥98%

MedChem Express

(+)-SJ733 is a clinical candidate for malaria which can also inhibit Na+-ATPase PfATP4. IC50 & Target: Parasite, Na+-ATPase PfATP4[1] In Vitro: (+)-SJ733 binds to a single receptor site in P. falciparum-infected erythrocytes with equivalent affinity to its growth-inhibitory potency (kd=50 nM). (+)-SJ733 has not exhibited either significant safety liabilities at any dose in extensive profiling […]

More Information Supplier Page

(+)-SJ733 10mg  | ≥98%

MedChem Express

(+)-SJ733 is a clinical candidate for malaria which can also inhibit Na+-ATPase PfATP4. IC50 & Target: Parasite, Na+-ATPase PfATP4[1] In Vitro: (+)-SJ733 binds to a single receptor site in P. falciparum-infected erythrocytes with equivalent affinity to its growth-inhibitory potency (kd=50 nM). (+)-SJ733 has not exhibited either significant safety liabilities at any dose in extensive profiling […]

More Information Supplier Page

(+)-SJ733 50mg  | ≥98%

MedChem Express

(+)-SJ733 is a clinical candidate for malaria which can also inhibit Na+-ATPase PfATP4. IC50 & Target: Parasite, Na+-ATPase PfATP4[1] In Vitro: (+)-SJ733 binds to a single receptor site in P. falciparum-infected erythrocytes with equivalent affinity to its growth-inhibitory potency (kd=50 nM). (+)-SJ733 has not exhibited either significant safety liabilities at any dose in extensive profiling […]

More Information Supplier Page

(+)-SJ733 100mg  | ≥98%

MedChem Express

(+)-SJ733 is a clinical candidate for malaria which can also inhibit Na+-ATPase PfATP4. IC50 & Target: Parasite, Na+-ATPase PfATP4[1] In Vitro: (+)-SJ733 binds to a single receptor site in P. falciparum-infected erythrocytes with equivalent affinity to its growth-inhibitory potency (kd=50 nM). (+)-SJ733 has not exhibited either significant safety liabilities at any dose in extensive profiling […]

More Information Supplier Page

(+)-Talarozole 10mM/1mL  | ≥98%

MedChem Express

(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(+)-Talarozole 5mg  | ≥98%

MedChem Express

(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(+)-Talarozole 10mg  | ≥98%

MedChem Express

(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(+)-Talarozole 25mg  | ≥98%

MedChem Express

(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(+)-Talarozole 50mg  | ≥98%

MedChem Express

(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(+)-Talarozole 1mg  | ≥98%

MedChem Express

(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1. IC50 & Target: retinoic acid[1]

More Information Supplier Page

(+)-Tetrabenazine D6 5mg  | ≥98%

MedChem Express

(+)-Tetrabenazine D6 is the deuterium labeled (+)-Tetrabenazine. (+)-Tetrabenazine is a reversible inhibitor of vesicular monoamine transporter 2 (VMAT-2).

More Information Supplier Page

(+)-Tetrabenazine D6 10mg  | ≥98%

MedChem Express

(+)-Tetrabenazine D6 is the deuterium labeled (+)-Tetrabenazine. (+)-Tetrabenazine is a reversible inhibitor of vesicular monoamine transporter 2 (VMAT-2).

More Information Supplier Page